[The pathogenesis of hemolysis observed during the evolution of a hemangioendotheliosarcoma of the spleen (author's transl)].
D000743:Anemia, Hemolytic / Q000209:etiology*; D001772:Blood Cell Count; D001780:Blood Coagulation Tests; D001859:Bone Neoplasms / Q000097:blood / Q000150:complications* / Q000188:drug therapy; D004211:Disseminated Intravascular Coagulation / Q000209:etiology; D006394:Hemangiosarcoma / Q000097:blood / Q000150:complications* / Q000188:drug therapy / Q000473:pathology; D006493:Heparin / Q000627:therapeutic use; D006529:Hepatomegaly / Q000209:etiology; D006801:Humans; D006854:Hydrocortisone / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D009362:Neoplasm Metastasis; D013156:Splenectomy; D013160:Splenic Neoplasms / Q000097:blood / Q000150:complications* / Q000188:drug therapy / Q000473:pathology; D013163:Splenomegaly / Q000209:etiology
D006493:Heparin; D006854:Hydrocortisone
Essai d'interprétation pathogénique de l'hémolyse au cours d'un hémangio-endothéliosarcome à début splénique